Skip to content

Neuronetics STIM EV / sales

EV / sales at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
1.8×-0.4×
CVRx, Inc. logo
CVRx, Inc.CVRX
-1.0×
Stereotaxis logo
StereotaxisSTXS
5.4×+0.1×
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-0.3×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.3×-0.4×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
7.3×-2.6×

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-56.2%
Enterprise value$162.64M-42.0%
P/S0.6×-1.3×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Calculated from Neuronetics’s reported figures.

Based on the most recent quarter.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's EV / sales?
Neuronetics (STIM) reported EV / sales of 1.1× in Q1 2026.
How has Neuronetics's EV / sales changed year-over-year?
Neuronetics's EV / sales decreased by 66.2% year-over-year, from 3.4× to 1.1×.
What is the long-term trend for Neuronetics's EV / sales?
Over 5 years (2020 to 2025), Neuronetics's EV / sales has grown at a -28.8% compound annual growth rate (CAGR), from 5.7× to 1.1×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.